Aplastic anemia is not a type of cancer, but it can increase the risk of developing leukemia. Aplastic anemia occurs when the bone marrow no longer produces blood cells. Anything that damages stem ...

Severe aplastic anemia is a rare blood disorder where an autoimmune reaction leads to your bone marrow not producing enough blood cells. Depending on the severity of aplastic anemia symptoms, doctors ...

Experts provide an update regarding current understanding and management of aplastic anemia in a new review. 1 Eliska Furlong, MD, PhD, with the Perth Children’s Hospital, in Australia, and colleague ...

Study findings showed 86% of patients had early and sustained neutrophil recovery at 100 days. The Food and Drug Administration (FDA) has approved Omisirge ® (omidubicel-onlv) for adults and pediatric ...

What Is Omisirge, and Why Does It Matter? Omisirge (omidubicel-onlv) is a type of cell therapy made from umbilical cord blood. It helps your body make new blood cells after a stem cell transplant.

Hematology refers to the study of blood and bone marrow conditions. A person may be referred to a hematologist to find out what the cause of anemia is and to determine a treatment plan. Anemia occurs ...

A Prescription Drug User Fee Act target date of December 10, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics ...

Eltrombopag combined with immunosuppressive therapy in pediatric patients with severe aplastic anemia achieved a 54.9% overall response rate at 26 weeks, with a 71.4% response in relapsed/refractory ...

Aplastic anemia is when your bone marrow can’t make enough healthy blood cells, including red blood cells, white blood cells, and platelets. A CBC measures blood cell levels and is used to diagnose ...

Post transplant erythrocytosis (PTE) is a known complication after renal transplantation, seen in 10–15% of cases. 1 Its occurrence has not been reported following allogeneic hemopoietic stem cell ...

Please provide your email address to receive an email when new articles are posted on . Outcomes after haploidentical transplant for severe aplastic anemia have improved significantly with use of post ...